GB202117007D0 - New pharmaceutical composition - Google Patents
New pharmaceutical compositionInfo
- Publication number
- GB202117007D0 GB202117007D0 GBGB2117007.1A GB202117007A GB202117007D0 GB 202117007 D0 GB202117007 D0 GB 202117007D0 GB 202117007 A GB202117007 A GB 202117007A GB 202117007 D0 GB202117007 D0 GB 202117007D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- pharmaceutical composition
- new pharmaceutical
- new
- composition
- pharmaceutical
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
- A61M11/02—Sprayers or atomisers specially adapted for therapeutic purposes operated by air or other gas pressure applied to the liquid or other product to be sprayed or atomised
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
- A61M15/003—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using capsules, e.g. to be perforated or broken-up
- A61M15/0043—Non-destructive separation of the package, e.g. peeling
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
- A61M15/0061—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using pre-packed dosages having an insert inside
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/08—Inhaling devices inserted into the nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/07—General characteristics of the apparatus having air pumping means
- A61M2205/071—General characteristics of the apparatus having air pumping means hand operated
- A61M2205/073—Syringe, piston type
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB2117007.1A GB202117007D0 (en) | 2021-11-25 | 2021-11-25 | New pharmaceutical composition |
PCT/GB2022/052984 WO2023094817A1 (en) | 2021-11-25 | 2022-11-25 | Pharmaceutical composition comprising atropine |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB2117007.1A GB202117007D0 (en) | 2021-11-25 | 2021-11-25 | New pharmaceutical composition |
Publications (1)
Publication Number | Publication Date |
---|---|
GB202117007D0 true GB202117007D0 (en) | 2022-01-12 |
Family
ID=79601787
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB2117007.1A Ceased GB202117007D0 (en) | 2021-11-25 | 2021-11-25 | New pharmaceutical composition |
Country Status (2)
Country | Link |
---|---|
GB (1) | GB202117007D0 (en) |
WO (1) | WO2023094817A1 (en) |
Citations (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5702362A (en) | 1995-05-26 | 1997-12-30 | Bayer Aktiengesellschaft | Nasal applicator |
US6398074B1 (en) | 1998-03-10 | 2002-06-04 | Valois S.A. | Reservoir, reservoir filling method and device for dispensing fluid contained in the reservoir |
US20050001411A1 (en) | 2001-09-06 | 2005-01-06 | Christian Theiss | Method for the determination of parameters of a seat passenger |
US6938798B2 (en) | 2000-12-08 | 2005-09-06 | Tebro S.A. | Fluid or powdery product dispensing device |
US7722566B2 (en) | 2003-10-09 | 2010-05-25 | Shin Nippon Biomedical Laboratories, Ltd. | Device to deliver a powdery medicine into nasal cavity |
WO2010142696A1 (en) | 2009-06-11 | 2010-12-16 | Charité - Universitätsmedizin Berlin | Use of opioid receptor antagonists for acute treatment of paraphilic arousal states |
US20110045088A1 (en) | 2009-07-31 | 2011-02-24 | Shin Nippon Biomedical Laboratories, Ltd. | Intranasal granisetron and nasal applicator |
US7947742B2 (en) | 2002-06-28 | 2011-05-24 | Civitas Therapeutics, Inc. | Inhalable epinephrine |
WO2014004400A2 (en) | 2012-06-28 | 2014-01-03 | The Governt. Of The Usa As Represented By The Secretary Of The Department Of Health & Human Services | Nasal dry powder delivery system for vaccines and other treatment agents |
US9724713B2 (en) | 2013-07-05 | 2017-08-08 | Aptar France Sas | Fluid or powdery product dispensing device |
US20180092839A1 (en) | 2016-10-03 | 2018-04-05 | Lance L. Gooberman | Medicated spray for treatment of substance abuse, overdose, addiction and impulse control disorders |
WO2019038756A1 (en) | 2017-08-20 | 2019-02-28 | Solubest Ltd. | Dry powder compositions for intranasal delivery |
US10653690B1 (en) | 2019-07-09 | 2020-05-19 | Orexo Ab | Pharmaceutical composition for nasal delivery |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2003205226A1 (en) * | 2002-01-18 | 2003-09-02 | Mannkind Corporation | Compositions for treatment or prevention of bioterrorism |
CN107929334A (en) * | 2017-11-13 | 2018-04-20 | 常州凯途纺织品有限公司 | A kind of preparation method of micro-capsule antiacid |
FR3098420B1 (en) | 2019-07-10 | 2021-07-09 | Aptar France Sas | Nasal powder dispenser |
FR3121047B1 (en) | 2021-03-29 | 2023-07-14 | Aptar France Sas | Nasal powder delivery device |
-
2021
- 2021-11-25 GB GBGB2117007.1A patent/GB202117007D0/en not_active Ceased
-
2022
- 2022-11-25 WO PCT/GB2022/052984 patent/WO2023094817A1/en unknown
Patent Citations (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5702362A (en) | 1995-05-26 | 1997-12-30 | Bayer Aktiengesellschaft | Nasal applicator |
US6398074B1 (en) | 1998-03-10 | 2002-06-04 | Valois S.A. | Reservoir, reservoir filling method and device for dispensing fluid contained in the reservoir |
US6938798B2 (en) | 2000-12-08 | 2005-09-06 | Tebro S.A. | Fluid or powdery product dispensing device |
US20050001411A1 (en) | 2001-09-06 | 2005-01-06 | Christian Theiss | Method for the determination of parameters of a seat passenger |
US8747813B2 (en) | 2002-06-28 | 2014-06-10 | Civitas Therapeutics, Inc. | Inhalable epinephrine |
US7947742B2 (en) | 2002-06-28 | 2011-05-24 | Civitas Therapeutics, Inc. | Inhalable epinephrine |
US8415397B2 (en) | 2002-06-28 | 2013-04-09 | Civitas Therapeutics, Inc. | Inhalable epinephrine |
US7722566B2 (en) | 2003-10-09 | 2010-05-25 | Shin Nippon Biomedical Laboratories, Ltd. | Device to deliver a powdery medicine into nasal cavity |
WO2010142696A1 (en) | 2009-06-11 | 2010-12-16 | Charité - Universitätsmedizin Berlin | Use of opioid receptor antagonists for acute treatment of paraphilic arousal states |
US20110045088A1 (en) | 2009-07-31 | 2011-02-24 | Shin Nippon Biomedical Laboratories, Ltd. | Intranasal granisetron and nasal applicator |
WO2014004400A2 (en) | 2012-06-28 | 2014-01-03 | The Governt. Of The Usa As Represented By The Secretary Of The Department Of Health & Human Services | Nasal dry powder delivery system for vaccines and other treatment agents |
US9724713B2 (en) | 2013-07-05 | 2017-08-08 | Aptar France Sas | Fluid or powdery product dispensing device |
US20180092839A1 (en) | 2016-10-03 | 2018-04-05 | Lance L. Gooberman | Medicated spray for treatment of substance abuse, overdose, addiction and impulse control disorders |
WO2019038756A1 (en) | 2017-08-20 | 2019-02-28 | Solubest Ltd. | Dry powder compositions for intranasal delivery |
US10653690B1 (en) | 2019-07-09 | 2020-05-19 | Orexo Ab | Pharmaceutical composition for nasal delivery |
Non-Patent Citations (14)
Title |
---|
"Amorphous Solid Dispersions", 2014, SPRINGER |
"Aulton's Pharmaceutics: The Design and Manufacture of Medicines", 2017, ELSEVIER |
"Pharmaceutical Dosage Forms: Tablets", vol. 1, 2008, CRC PRESS |
"'Remington: The Science and Practice of Pharmacy", 2020, PHARMACEUTICAL PRESS |
"The HLB System: A Time-Saving Guide to Emulsifier Selection", 1976, ICI AMERICAS INC, pages: 20 - 21 |
BERTAN ET AL., EUR. J. PHARM. SCI., vol. 27, 2006, pages 62 |
GANDHI, ADVANCED DRUG DELIVERY REVIEWS, vol. 43, 1994, pages 67 |
J. DRUG DELIVERY, vol. 5635010, 2018, pages 1 - 19 |
LACHMAN ET AL.: "The Theory and Practice of Industrial Pharmacy", 2015 |
MOHANACHANDRAN ET AL., INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES REVIEW AND RESEARCH, vol. 6, 2011, pages 105 |
ROWE ET AL.: "Handbook of Pharmaceutical Excipients", 2009 |
RUSSO ET AL., J. PHARM. SCI., vol. 95, 2006, pages 2253 |
SHOJAEI, J. PHARM. PHARMACEUTICAL SCI., vol. 15, 1998, pages 19 |
VENGEROVICH ET AL., BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, vol. 163, 2017, pages 737 |
Also Published As
Publication number | Publication date |
---|---|
WO2023094817A1 (en) | 2023-06-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB202019241D0 (en) | Pharmaceutical composition | |
IL304290A (en) | Pharmaceutical composition | |
GB201911517D0 (en) | Pharmaceutical composition | |
FI3908321T3 (en) | Pharmaceutical composition | |
GB202117015D0 (en) | New pharmaceutical composition | |
GB202117005D0 (en) | New pharmaceutical composition | |
GB202117007D0 (en) | New pharmaceutical composition | |
GB202018901D0 (en) | New pharmaceutical composition | |
GB202009905D0 (en) | New pharmaceutical composition | |
GB202007328D0 (en) | New pharmaceutical composition | |
GB202007306D0 (en) | New pharmaceutical composition | |
GB202208464D0 (en) | Pharmaceutical composition | |
GB202109271D0 (en) | Pharmaceutical composition | |
GB202108387D0 (en) | Pharmaceutical composition | |
GB202107518D0 (en) | Pharmaceutical composition | |
GB202105858D0 (en) | Pharmaceutical composition | |
GB202105462D0 (en) | Pharmaceutical composition | |
GB202105047D0 (en) | Pharmaceutical composition | |
GB202105049D0 (en) | Pharmaceutical composition | |
GB202104224D0 (en) | Pharmaceutical composition | |
GB202102095D0 (en) | Pharmaceutical composition | |
GB202102100D0 (en) | Pharmaceutical composition | |
GB202101634D0 (en) | Pharmaceutical composition | |
GB202101638D0 (en) | Pharmaceutical composition | |
GB202101640D0 (en) | Pharmaceutical composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |